{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifponxbh44pbgsrp7aagrvbls263su7cvits7q667fqa75t6y2664",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkcukjoykhu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifgqkksccezvi3ad53w7nojuozg3jb3aslhn3jsmm4j3k2fcga7xe"
    },
    "mimeType": "image/jpeg",
    "size": 40342
  },
  "path": "/2026/04/24/trump-psychedelic-drugs-fda-priority-review-mental-health-treatment/?utm_campaign=rss",
  "publishedAt": "2026-04-24T18:45:38.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Breaking News",
    "Business",
    "Health",
    "Pharma",
    "Politics",
    "addiction",
    "biotechnology",
    "drug development",
    "FDA",
    "HHS",
    "Mental Health",
    "Pharmaceuticals",
    "Policy",
    "research",
    "STAT+"
  ],
  "textContent": "Trump's embrace of psychedelics and cannabis is shaking up the GOP’s relationship with mind-altering substances.",
  "title": "STAT+: FDA to speed up review of three psychedelics as mental health treatments",
  "updatedAt": "2026-04-24T20:02:09.000Z"
}